SonR Based Stimulation-VECtor OPTimisation in CRT Patients
NCT ID: NCT03092349
Last Updated: 2019-02-06
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
10 participants
OBSERVATIONAL
2017-01-31
2018-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Atrio-Ventricular (AV) Delay Optimization Using Echocardiography Versus the SonR Signal
NCT01287234
Acute Optimization of Cardiac Resynchronization Therapy (CRT)Using Echocardiography and SonR
NCT01293526
Optimization of Cardiac Resynchronization Therapy by Non-Invasive Imaging of Cardiac Electrophysiology
NCT04662970
Response to Cardiac Resynchronization Therapy of Previously Right Ventricular Paced Heart Failure Patients
NCT01466621
Optimization of CRT Using an ECG Vest
NCT02699944
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Vector optimisation
Evaluation of hemodynamically best LV Stimulation vector and device programming according to measurements
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Implanted CRT-D system with SonR sensor technology
* Sinus rhythm
* NYHA class II-IV
* Age ≥ 18 years
* Written informed consent to participate in the study
Exclusion Criteria
* Patients with an insufficient SonR signal
* Confirmed pregnancy
* Age \< 18 years
* Life expectancy \< 1 year
* Atrial fibrillation / atrial flutter at the time of enrollment
* Unability to give informed consent
* Participation in another clinical study with active therapeutic arm
* Regular follow-up at the study site from enrolment to 12 months follow up not guaranteed
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Heart and Diabetes Center North-Rhine Westfalia
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Klaus-Jürgen Gutleben, MD
Role: PRINCIPAL_INVESTIGATOR
Clinic for Cardiology, Heart and Diabetes Center North Rhine-Westphalia
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Herz- und Diabeteszentrum NRW
Bad Oeynhausen, , Germany
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HDZNRW-KA-007_KJG
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.